Glucose Aguettant (Glucose Monohydrate)

Glucose Aguettant is used when a rapid increase in blood glucose is needed, typically in clinical settings that involve intravenous therapy.

• Treatment of hypoglycemia when oral glucose is not feasible.
• Energy source during surgery or anesthesia to maintain metabolic balance.
• Support for patients receiving parenteral nutrition who require carbohydrate supplementation.
• Management of electrolyte imbalances where glucose infusion helps intracellular fluid shifts.
• Use in diagnostic procedures such as glucose tolerance testing when administered intravenously.
• Adjunctive therapy for certain metabolic disorders under medical supervision.

Glucose Aguettant may be associated with a range of adverse reactions, most of which are related to the infusion of a carbohydrate solution.

Common

• Mild hyperglycemia or transient rise in blood glucose levels.
• Local irritation or pain at the infusion site.
• Nausea or mild gastrointestinal discomfort.
• Headache or dizziness during rapid infusion.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic reaction such as rash, itching, or anaphylaxis.
• Electrolyte disturbances, particularly hyponatremia.
• Fluid overload causing pulmonary edema.

When administering Glucose Aguettant, healthcare professionals should observe several precautionary measures to ensure patient safety and appropriate therapeutic effect.

• Verify patient’s blood glucose level before infusion to avoid excessive hyperglycemia.
• Adjust infusion rate in patients with renal or cardiac insufficiency to prevent fluid overload.
• Use aseptic technique to maintain sterility of the intravenous solution.
• Monitor electrolytes, especially sodium and potassium, during prolonged administration.
• Consider contraindications in patients with known hypersensitivity to glucose solutions.
• Assess for signs of infection at the catheter site throughout therapy.

Glucose Aguettant can interact with other medications or clinical conditions, and awareness of these interactions helps prevent complications.

Avoid

• Concurrent use of insulin or other hypoglycemic agents without dose adjustment, which may cause severe hypoglycemia.
• Co-administration with high‑dose diuretics that may exacerbate electrolyte imbalances.

Use with caution

• Concurrent intravenous fluids containing dextrose or other carbohydrates, to avoid cumulative glucose load.
• Patients receiving beta‑blockers, as they may mask symptoms of hypoglycemia.
• Use in combination with corticosteroids, which can increase blood glucose levels.